Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Other Accumulated Expenses (2019 - 2025)

AVITA Medical filings provide 7 years of Other Accumulated Expenses readings, the most recent being $2.6 million for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 100.53% to $2.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.6 million, a 100.53% increase, with the full-year FY2025 number at $2.6 million, up 100.53% from a year prior.
  • Other Accumulated Expenses hit $2.6 million in Q4 2025 for AVITA Medical, up from $2.1 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $2.6 million in Q4 2025 to a low of $949000.0 in Q2 2021.
  • Median Other Accumulated Expenses over the past 5 years was $1.3 million (2023), compared with a mean of $1.4 million.
  • Biggest five-year swings in Other Accumulated Expenses: crashed 40.23% in 2024 and later skyrocketed 111.45% in 2025.
  • AVITA Medical's Other Accumulated Expenses stood at $1.1 million in 2021, then decreased by 7.91% to $990000.0 in 2022, then grew by 27.88% to $1.3 million in 2023, then grew by 4.19% to $1.3 million in 2024, then surged by 100.53% to $2.6 million in 2025.
  • The last three reported values for Other Accumulated Expenses were $2.6 million (Q4 2025), $2.1 million (Q3 2025), and $1.8 million (Q2 2025) per Business Quant data.